223 related articles for article (PubMed ID: 23406984)
1. Malignant pleural effusion resulting from metastasis of thyroid primaries: a cytomorphological analysis.
Olson MT; Nuransoy A; Ali SZ
Acta Cytol; 2013; 57(2):177-83. PubMed ID: 23406984
[TBL] [Abstract][Full Text] [Related]
2. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
3. Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution.
Lew M; Pang JC; Roh MH; Jing X
Acta Cytol; 2015; 59(5):412-7. PubMed ID: 26587773
[TBL] [Abstract][Full Text] [Related]
4. Hürthle cell carcinoma of the thyroid with contralateral malignant pleural effusion.
Hsu KF; Hsieh CB; Duh QY; Chien CF; Li HS; Shih ML
Onkologie; 2009 Feb; 32(1-2):47-9. PubMed ID: 19209020
[TBL] [Abstract][Full Text] [Related]
5. Metastatic thyroid carcinoma presenting as malignant pleural effusion: A cytologic review of 5 cases.
Vyas M; Harigopal M
Diagn Cytopathol; 2016 Dec; 44(12):1085-1089. PubMed ID: 27456348
[TBL] [Abstract][Full Text] [Related]
6. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
Jo VY; Cibas ES; Pinkus GS
Cancer Cytopathol; 2014 Apr; 122(4):299-306. PubMed ID: 24421209
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
8. Deaths due to differentiated thyroid cancer: a South Island, New Zealand experience: 1984-2009.
Brownlie BJ; Turner J; Abdelaal AS
N Z Med J; 2012 Oct; 125(1363):13-21. PubMed ID: 23159897
[TBL] [Abstract][Full Text] [Related]
9. Malignant pleural effusion from papillary thyroid carcinoma diagnosed by pleural effusion cytology: A case report.
Kosmas K; Tsonou A; Mitropoulou G; Salemi E; Kazi D; Theofanopoulou A
Diagn Cytopathol; 2018 Feb; 46(2):204-207. PubMed ID: 28960907
[TBL] [Abstract][Full Text] [Related]
10. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
11. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
12. Pleural effusion in patients with differentiated papillary thyroid cancer.
Vassilopoulou-Sellin R; Sneige N
South Med J; 1994 Nov; 87(11):1111-6. PubMed ID: 7973894
[TBL] [Abstract][Full Text] [Related]
13. Malignant effusion of chromophobe renal-cell carcinoma: cytological and immunohistochemical findings.
Teresa P; Grazia ZM; Doriana M; Irene P; Michele S
Diagn Cytopathol; 2012 Jan; 40(1):56-61. PubMed ID: 22180239
[TBL] [Abstract][Full Text] [Related]
14. [Extensive pulmonary tumor embolisms of anaplastic thyroid gland carcinoma as a rare cause of hemorrhagic pleural effusion in an 88-year-old patient].
Köppl H; Scheer E; Herbst EW
Pneumologie; 1993 Oct; 47(10):593-6. PubMed ID: 8259368
[TBL] [Abstract][Full Text] [Related]
15. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
17. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
Hyun TS; Barnes M; Tabatabai ZL
Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
Gaspar MJ; De Miguel J; García Díaz JD; Díez M
Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
[TBL] [Abstract][Full Text] [Related]
20. De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology.
Cioc AM; Jessurun J; Vercellotti GM; Pambuccian SE
Diagn Cytopathol; 2014 Mar; 42(3):259-67. PubMed ID: 23007953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
